erythromycin has been researched along with Brain Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gou, D; Han, S; Li, G; Lu, W; Si, M; Yang, R | 1 |
| Guo, ZZ; Li, GY; Lu, WC; Qiu, B; Xie, H; Yang, RM | 1 |
| Inaba, T; Katayama, Y; Katsura, K; Nito, C; Ueda, M | 1 |
| Ampatzidou, FC; Ananiadou, OG; Charchanti, AV; Drossos, GE; Johnson, EO; Koutsogiannidis, CP; Mytilinaios, DG; Nikolopoulou, EN; Savvas, IP; Troupis, TG | 1 |
| Brambrink, AM; Gatting, M; Kempski, O; Koerner, IP; Noppens, R | 1 |
| Huber, R; Kasischke, K; Ludolph, AC; Riepe, MW | 1 |
6 other study(ies) available for erythromycin and Brain Ischemia
| Article | Year |
|---|---|
Protective Effect of Erythromycin Pre-adaptation on Focal Cerebral Ischemia in Rats and its Changes in TNF-α and nNOS.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Erythromycin; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; RNA, Messenger; Tumor Necrosis Factor-alpha | 2023 |
Erythromycin pretreatment induces tolerance against focal cerebral ischemia through up-regulation of nNOS but not down-regulation of HIF-1α in rats.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Disease Models, Animal; Down-Regulation; Erythromycin; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide Synthase Type I; Random Allocation; Rats, Wistar; RNA, Messenger; Severity of Illness Index; Up-Regulation | 2014 |
Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells.
Topics: Animals; Brain Edema; Brain Ischemia; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Erythromycin; Glucose; Hemiplegia; Infarction, Middle Cerebral Artery; Male; Neuroimmunomodulation; Neurons; Neuroprotective Agents; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
Decreased DNA Disruption in the Porcine Neocortex with Erythromycin Preconditioning during Prolonged Hypothermic Circulatory Arrest: Evidence for Neuroprotection.
Topics: Animals; Apoptosis; Brain Ischemia; Depression, Chemical; Disease Models, Animal; DNA Fragmentation; Erythromycin; Heart Arrest, Induced; Hypothermia, Induced; Ischemic Preconditioning; Neocortex; Neurons; Neuroprotection; Neuroprotective Agents; Rats; Swine; Time Factors | 2015 |
Induction of cerebral ischemic tolerance by erythromycin preconditioning reprograms the transcriptional response to ischemia and suppresses inflammation.
Topics: Animals; Anti-Bacterial Agents; Brain; Brain Ischemia; Disease Models, Animal; DNA, Complementary; Erythromycin; Inflammation; Ischemic Preconditioning; Male; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2007 |
Increase of cellular hypoxic tolerance by erythromycin and other antibiotics.
Topics: Ampicillin; Analysis of Variance; Animals; Anti-Bacterial Agents; Brain Ischemia; Cell Hypoxia; Cytoprotection; Drug Evaluation, Preclinical; Erythromycin; Fluorometry; Hippocampus; In Vitro Techniques; Kanamycin; Male; NAD; Neuroprotective Agents; Rats; Rats, Wistar; Risk Factors | 1999 |